You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Dynamic Frequency Passive Millimeter-Wave Radiometer Based on Optical Up-Conversion

    SBC: PHASE SENSITIVE INNOVATIONS INC            Topic: 941D

    In the proposed effort, we will leverage this extensive experience and capabilities to realize a frequency agile mmW radiometer that can cover the range of DC-110 GHz and can be scaled to DC-200 GHz under Phase II. Ours is a photonic system that multiplies and up-coverts a low-frequency reference signal onto an optical carrier (laser) using EO modulation, then uses the modulation sidebands to inj ...

    SBIR Phase I 2013 Department of CommerceNational Oceanic and Atmospheric Administration
  2. A collagen wound dressing augmented with a proteoglycan mimic to enhance chronic

    SBC: Angion Biomedica Corp.            Topic: NIAAA

    DESCRIPTION (provided by applicant): Liver fibrosis is a form of scar formation that is found in almost all patients with chronic injury to the liver. Over time it frequently progresses to cirrhosis, an end-stage lethal disease which is the seventh leadingcause of death in the United States and afflicts hundreds of millions of people worldwide. Alcohol intake remains the most important cause of li ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  3. Reversal of Myocardial Infarction by Localized Stimulation

    SBC: GISMO THERAPEUTICS INC.            Topic: NIA

    DESCRIPTION (provided by applicant): The aim of this proposal is to develop a novel class of Alzheimer's Disease (AD) therapeutics acting via a hitherto unexplored mechanism of action. AD is the sixth-leading cause of death in the United States with no known cure. The burden on families and caregivers of patients is immense, with the annual cost of care approaching 1 trillion. The exorbitant ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  4. A novel, multiparametric cardiac safety assay using human myocytes

    SBC: THERAPYX, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Genital tract infection with Neisseria gonorrhoeae (gonorrhea) does not induce a state of specific protective immunity and can be acquired repeatedly. Despite public health measures, the disease persists at an unacceptably high frequency; there is no vaccine against it, and resistance even to the latest generations of antibiotics continues to emerge. New findin ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Software for improved accuracy and rapid tracking of kinematics from dynamic Xray

    SBC: TECHNOVAX INC            Topic: NIAID

    DESCRIPTION (provided by applicant): We propose to develop a broadly neutralizing, possibly universal influenza vaccine based on virus-like particles (VLPs) displaying remodeled HA molecules which present otherwise cryptic epitopes. These remodeled HAs will be expressed in forms lacking the dominant hypervariable epitopes and instead display distinctly conserved subdominant antigenic sites known t ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Development of Adult Pluripotent Very Small Embryonic Like (VSEL) Stem Cells to T

    SBC: Caladrius Biosciences            Topic: NIAMS

    DESCRIPTION (provided by applicant): Scleroderma is an autoimmune, connective tissue disorder which causes fibrosis of the skin and internal organs. In the skin, there is overproduction of extracellular matrix, and type 1 and 3 collagen. The disease involves vascular breakdown where the blood vessels in the skin degenerate and are replaced by collagen to form fibrotic tissue. The sclerotic tissue ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Low-Dose MRI-Compatible Molecular Breast Imaging Device

    SBC: EMPIRE GENOMICS LLC            Topic: NCI

    DESCRIPTION (provided by applicant): Multiple myeloma is a malignant plasma cell cancer that is increasing in frequency in today's aging population. While new combination therapies have improved the outcome of treatment, many patients fail to achieve a complete remission and ultimately the disease progresses. With these new treatments come higher associated toxicities and significant healthca ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Injectable microgel for soft tissue repair

    SBC: DAYSAI BIOPHARMACEUTICALS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): BCL6 is the most commonly involved oncogene in B-cell lymphomas, and is expressed constitutively in a majority of patients with the two most frequent forms of lymphoma: the diffuse large B-cell lymphomas (DLBCL) and follicular lymphoma (FL). Many of these BCL6 positive tumors require the continued presence of BCL6 in order to maintain their survival. BCL6, a me ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. HIGHLY EFFICIENT CEREBRAL PERFUSION MRI

    SBC: BIOTHERYX, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Pancreatic Ductal Adenocarcinoma (PDAC) is the most common and deadliest form of pancreatic cancer. It is an extremely difficult-to-treat disease with a median survival of less than 1 year and a dismal 5-year survival rate of 3-5%. This is primarily due to a rapid dissemination of the tumors and a lack of effective biomarkers for early detection which means th ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Aldosterone Synthase Inhibitor for CKD

    SBC: Angion Biomedica Corp.            Topic: NIDDK

    DESCRIPTION (provided by applicant): The renin-angiotensin-aldosterone system (RAAS) plays a critical role in renal physiology. Inhibitors of angiotensin-converting enzyme (ACE) or angiotensin receptor blockers (ARB) are the mainstay in the clinical management of renal disorders such as chronic kidney disease (CKD). These treatments are thought to work in large part by reducing serum and renal ald ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government